Advanced Search
GAO Yuanyue, LIU Aiyun, SHEN Jiajia, DING Ya. Advances in asialoglycoprotein receptor-mediated liver cancer targeted drug delivery system[J]. Journal of China Pharmaceutical University, 2016, 47(5): 537-542. DOI: 10.11665/j.issn.1000-5048.20160505
Citation: GAO Yuanyue, LIU Aiyun, SHEN Jiajia, DING Ya. Advances in asialoglycoprotein receptor-mediated liver cancer targeted drug delivery system[J]. Journal of China Pharmaceutical University, 2016, 47(5): 537-542. DOI: 10.11665/j.issn.1000-5048.20160505

Advances in asialoglycoprotein receptor-mediated liver cancer targeted drug delivery system

  • Asialoglycoprotein receptor(ASGPR)is a receptor expressed mainly on the surface of liver sinusoidal and basolateral cells. It can exclusively identity, combine and clear desialylated glycoproteins with exposed non-reducing D-galactose(Gal)or nacetylgalactosamine(GalNAc)as end groups. Based on this characteristic, ASGPR-mediated targeted liver cancer therapy has drawn extensive attention. The present review details the latest research progress of this field in three aspects, glycosylated prodrug, small molecular nanocarriers, and glycosylated gene complex therapy system.
  • loading

Catalog

    Turn off MathJax
    Article Contents

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return